Recommendations for optimal gestational weight gain are different depending on a woman's body mass index (BMI), ranging from ...

Background Guidelines strongly recommend reperfusion therapy, including thrombolysis and percutaneous coronary intervention, ...

Diabetes drugs such as semaglutide already have a reputation for lowering the risk of cardiovascular events in people with ...

The 37th Annual Transcatheter Cardiovascular Therapeutics (TCT2025) symposium was held grandly in San Francisco, USA, ...

Cordis, a global leader in interventional cardiovascular technology, announced the groundbreaking results from the SELUTION ...

Background Pain and fatigue are among the most debilitating symptoms of systemic sclerosis (SSc), severely impairing quality ...

Adding the PCSK9 inhibitor evolocumab to standard lipid-lowering therapy significantly reduced first major cardiovascular ...

Background Relationships and sex education (RSE) impacts some sexual behaviours but could be strengthened by incorporating ...

LDL cholesterol level < 40 vs ≥ 70 mg/dL is linked to lower rates of future major cardiovascular events in patients with ...

Icotrokinra, a targeted oral peptide that selectively binds the interleukin-23 receptor, is under investigation for the ...

Introduction Burnout and reduced well-being are highly prevalent among Japanese medical students during clinical training. Scalable, evidence-based interventions are urgently needed. This protocol ...

Amylin receptor agonists are gaining attention as a new class of anti-obesity drugs. Eloralintide, a novel and selective long ...